Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
by on Tuesday, August 7th, 2012 | No Comments
Conditions: Multiple Myeloma; Leukemia, Plasma Cell
Interventions: Drug: Carfilzomib; Drug: Melphalan; Drug: Filgrastim
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting – verified July 2012
The rest is here: Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma